Coherus Oncology

1. Tagmokitug HNSCC Ph1 interimMid-2026Tagmokitug HNSCC Ph1 interim, Mid-2026, notable
2. Tagmokitug ESCC Ph1 interim2H 2026Tagmokitug ESCC Ph1 interim, 2H 2026, notable
3. Tagmokitug MSS Ph1 interim2H 2026Tagmokitug MSS Ph1 interim, 2H 2026, notable
4. Tagmokitug + pasritamig Ph1 startFall 2026Tagmokitug + pasritamig Ph1 start, Fall 2026, routine
5. CVR corporate updateSep 29, 2026CVR corporate update, Sep 29, 2026, routine
6. UDENYCA corporate updateSep 30, 2026UDENYCA corporate update, Sep 30, 2026, routine
7. CVR / UDENYCA Earnout corporateSep 30, 2026CVR / UDENYCA Earnout corporate, Sep 30, 2026, routine
8. Casdozokitug Ph2 toplineOct 2026Casdozokitug Ph2 topline, Oct 2026, thesis-defining
9. UDENYCA corporate updateMar 31, 2027UDENYCA corporate update, Mar 31, 2027, routine
10. Term B Loan filingSep 1, 2027Term B Loan filing, Sep 1, 2027, routine

Bar width shows how precise the guidance is — a pin is a stated date, a wide band a six-month window. Deeper blue means more of the thesis rides on the event; it is not a view on the stock.